| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
369,212 |
315,328 |
$15.64M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
158,661 |
125,771 |
$7.54M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
65,948 |
57,716 |
$3.41M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
33,749 |
30,865 |
$2.70M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
31,626 |
27,070 |
$2.22M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
23,188 |
21,301 |
$1.84M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
46,159 |
42,800 |
$1.81M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17,882 |
16,277 |
$1.71M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23,028 |
21,055 |
$1.08M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
9,329 |
8,179 |
$809K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
26,835 |
24,263 |
$765K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,009 |
2,705 |
$387K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
9,824 |
8,701 |
$307K |
| 92551 |
|
29,233 |
26,098 |
$242K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,784 |
1,700 |
$236K |
| 87428 |
|
4,250 |
3,589 |
$232K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
27,862 |
24,677 |
$221K |
| 80061 |
Lipid panel |
22,037 |
19,677 |
$202K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
15,190 |
7,032 |
$186K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,559 |
2,282 |
$180K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,238 |
11,822 |
$168K |
| 96161 |
|
16,374 |
14,253 |
$167K |
| 96127 |
|
29,859 |
26,219 |
$158K |
| 99177 |
|
21,637 |
19,408 |
$155K |
| 36415 |
Collection of venous blood by venipuncture |
109,039 |
84,484 |
$147K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,827 |
8,827 |
$136K |
| 80050 |
General health panel |
4,218 |
3,817 |
$123K |
| 96160 |
|
15,439 |
13,122 |
$122K |
| 80053 |
Comprehensive metabolic panel |
21,063 |
18,725 |
$112K |
| 99173 |
|
18,170 |
16,252 |
$98K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,631 |
1,280 |
$97K |
| 99381 |
|
1,189 |
991 |
$88K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,164 |
5,171 |
$74K |
| 83655 |
|
4,208 |
3,728 |
$62K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,559 |
2,282 |
$60K |
| 90686 |
|
18,962 |
16,499 |
$43K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
786 |
704 |
$41K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
631 |
491 |
$41K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
520 |
473 |
$41K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
813 |
745 |
$41K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,381 |
1,189 |
$41K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
3,270 |
2,123 |
$40K |
| 36416 |
|
27,286 |
23,412 |
$40K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,762 |
751 |
$38K |
| 87634 |
|
536 |
509 |
$38K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
346 |
240 |
$34K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,682 |
5,833 |
$34K |
| 90834 |
Psychotherapy, 45 minutes with patient |
793 |
573 |
$28K |
| 95886 |
|
575 |
323 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,852 |
2,558 |
$28K |
| 87430 |
|
2,141 |
2,002 |
$28K |
| 81003 |
|
14,483 |
12,003 |
$27K |
| 90670 |
|
16,672 |
14,439 |
$25K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
325 |
301 |
$23K |
| 92015 |
Determination of refractive state |
856 |
841 |
$23K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,057 |
265 |
$19K |
| 85027 |
|
4,249 |
3,822 |
$17K |
| 90651 |
|
2,929 |
2,615 |
$16K |
| 90461 |
|
34,874 |
31,012 |
$15K |
| 99174 |
|
1,199 |
1,060 |
$14K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
2,503 |
1,847 |
$14K |
| 88720 |
|
2,333 |
1,521 |
$13K |
| 99233 |
Prolong inpt eval add15 m |
452 |
218 |
$12K |
| 90688 |
|
3,536 |
3,095 |
$12K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,465 |
2,518 |
$11K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
435 |
427 |
$10K |
| 84439 |
|
1,117 |
1,018 |
$10K |
| 90837 |
Psychotherapy, 53 minutes with patient |
178 |
88 |
$9K |
| 90832 |
Psychotherapy, 30 minutes with patient |
264 |
122 |
$9K |
| 92552 |
|
427 |
363 |
$8K |
| 87631 |
|
87 |
71 |
$8K |
| 99307 |
|
1,197 |
881 |
$8K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
604 |
400 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
236 |
181 |
$7K |
| 87807 |
|
567 |
540 |
$7K |
| 84466 |
|
582 |
523 |
$7K |
| 90674 |
|
808 |
730 |
$7K |
| 99383 |
|
88 |
61 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
378 |
357 |
$7K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
368 |
306 |
$6K |
| 82728 |
|
486 |
436 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
390 |
368 |
$6K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
666 |
139 |
$6K |
| 83525 |
|
497 |
426 |
$6K |
| 99223 |
Prolong inpt eval add15 m |
98 |
84 |
$6K |
| 90723 |
|
14,110 |
12,327 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
247 |
215 |
$5K |
| 82607 |
|
419 |
361 |
$5K |
| 90734 |
|
1,541 |
1,315 |
$5K |
| 90756 |
|
374 |
300 |
$5K |
| 92136 |
|
689 |
483 |
$5K |
| 90716 |
|
1,942 |
1,763 |
$5K |
| 90633 |
|
7,688 |
6,859 |
$4K |
| 99382 |
|
86 |
53 |
$4K |
| 90710 |
|
907 |
817 |
$4K |
| 90739 |
|
26 |
24 |
$4K |
| 90680 |
|
12,455 |
10,874 |
$4K |
| 83540 |
|
626 |
561 |
$4K |
| 84681 |
|
161 |
154 |
$4K |
| 0012A |
|
108 |
75 |
$4K |
| 96380 |
|
180 |
139 |
$4K |
| 86803 |
|
254 |
238 |
$4K |
| 92134 |
|
437 |
346 |
$3K |
| 90707 |
|
1,962 |
1,778 |
$3K |
| V2100 |
Sphere, single vision, plano to plus or minus 4.00, per lens |
167 |
167 |
$3K |
| 82465 |
|
976 |
830 |
$3K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
836 |
199 |
$3K |
| V2020 |
Frames, purchases |
194 |
193 |
$3K |
| 99441 |
|
254 |
190 |
$3K |
| 99051 |
|
812 |
770 |
$3K |
| 90746 |
|
40 |
35 |
$3K |
| 0011A |
|
77 |
48 |
$3K |
| 0001A |
|
117 |
65 |
$2K |
| 90661 |
|
1,798 |
1,567 |
$2K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
105 |
98 |
$2K |
| 0002A |
|
83 |
45 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
3,350 |
1,867 |
$2K |
| 69210 |
|
78 |
64 |
$2K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
21 |
12 |
$2K |
| 90715 |
|
353 |
312 |
$2K |
| 94760 |
|
3,775 |
3,297 |
$2K |
| 99215 |
Prolong outpt/office vis |
47 |
30 |
$2K |
| 87081 |
|
315 |
273 |
$2K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
33 |
27 |
$2K |
| 90648 |
|
16,087 |
14,401 |
$2K |
| 90671 |
|
3,907 |
3,644 |
$1K |
| 99222 |
Initial hospital care, per day, moderate complexity |
29 |
27 |
$1K |
| 0071A |
|
54 |
34 |
$1K |
| 91320 |
|
21 |
13 |
$1K |
| 82962 |
|
1,289 |
873 |
$1K |
| 0072A |
|
36 |
22 |
$1K |
| 85018 |
|
351 |
317 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
93 |
67 |
$1K |
| 90696 |
|
945 |
847 |
$1K |
| 99406 |
|
141 |
121 |
$1K |
| 90677 |
|
454 |
431 |
$1K |
| 99384 |
|
16 |
12 |
$996.54 |
| 90791 |
Psychiatric diagnostic evaluation |
14 |
12 |
$962.57 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,233 |
781 |
$945.02 |
| 97161 |
|
14 |
13 |
$942.67 |
| 86140 |
|
419 |
375 |
$806.38 |
| 99497 |
|
14 |
12 |
$793.06 |
| 87420 |
|
62 |
59 |
$786.45 |
| J9035 |
Injection, bevacizumab, 10 mg |
39 |
27 |
$779.07 |
| 92002 |
|
12 |
12 |
$747.46 |
| 93000 |
|
65 |
49 |
$581.91 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
24 |
17 |
$572.16 |
| 82570 |
|
280 |
193 |
$561.27 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$560.90 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$560.84 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
151 |
141 |
$496.85 |
| 90658 |
|
38 |
29 |
$476.16 |
| 99442 |
|
31 |
24 |
$466.20 |
| 90647 |
|
2,291 |
1,972 |
$451.44 |
| 90620 |
|
55 |
55 |
$436.00 |
| 99217 |
|
12 |
12 |
$417.83 |
| 90480 |
|
19 |
13 |
$369.69 |
| G0008 |
Administration of influenza virus vaccine |
1,543 |
1,040 |
$369.38 |
| 94761 |
|
43 |
30 |
$366.20 |
| 82044 |
|
256 |
176 |
$365.55 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
46 |
39 |
$325.91 |
| 82550 |
|
66 |
59 |
$260.93 |
| 83735 |
|
62 |
55 |
$260.09 |
| 82746 |
|
34 |
26 |
$258.43 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
131 |
97 |
$198.50 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
967 |
533 |
$196.99 |
| 90672 |
|
105 |
100 |
$178.71 |
| 85652 |
|
161 |
144 |
$171.76 |
| 90474 |
|
29 |
24 |
$169.33 |
| 99318 |
|
18 |
14 |
$166.54 |
| 81025 |
|
18 |
14 |
$146.98 |
| 90656 |
|
482 |
468 |
$137.51 |
| 90700 |
|
515 |
476 |
$133.45 |
| 90630 |
|
25 |
14 |
$125.90 |
| 81001 |
|
42 |
39 |
$115.92 |
| 83721 |
|
39 |
38 |
$110.64 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
15 |
15 |
$105.02 |
| 90660 |
|
67 |
67 |
$86.55 |
| 82043 |
|
31 |
25 |
$85.06 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
304 |
288 |
$81.58 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
182 |
171 |
$75.41 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
115 |
97 |
$74.73 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
12 |
$56.86 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
12 |
$41.21 |
| 0064A |
|
18 |
12 |
$40.00 |
| J3490 |
Unclassified drugs |
19 |
13 |
$30.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
165 |
157 |
$12.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13 |
12 |
$9.64 |
| 91300 |
|
40 |
16 |
$0.19 |
| 1159F |
|
610 |
328 |
$0.02 |
| 91307 |
|
37 |
18 |
$0.01 |
| 3008F |
|
101 |
97 |
$0.00 |
| 99000 |
|
925 |
815 |
$0.00 |
| 90698 |
|
666 |
586 |
$0.00 |
| 90744 |
|
311 |
280 |
$0.00 |
| 1170F |
|
583 |
316 |
$0.00 |
| 1111F |
|
1,293 |
890 |
$0.00 |
| 90694 |
|
56 |
33 |
$0.00 |
| 90381 |
|
35 |
27 |
$0.00 |
| 3074F |
|
58 |
56 |
$0.00 |
| 90619 |
|
16 |
14 |
$0.00 |
| 2023F |
|
32 |
32 |
$0.00 |
| 99397 |
|
363 |
199 |
$0.00 |
| 90685 |
|
497 |
483 |
$0.00 |
| 1160F |
|
218 |
200 |
$0.00 |
| 90687 |
|
354 |
292 |
$0.00 |
| 90380 |
|
17 |
13 |
$0.00 |
| 99072 |
|
73 |
68 |
$0.00 |
| 90662 |
|
397 |
224 |
$0.00 |
| 99499 |
|
107 |
89 |
$0.00 |
| 3078F |
|
58 |
56 |
$0.00 |
| 90681 |
|
16 |
15 |
$0.00 |